AssayCheX verifies - and delivers - results.

Radix BioSolutions helps improve data quality and strengthen study results for Aviir, Inc.

A venture-funded biotechnology company, Aviir, Inc. develops cutting-edge, diagnostic tests for cardiovascular disease. With plans to introduce its first breakthrough product to market soon, Aviir is completing a series of studies that involve the profiling and selection of protein biomarkers instrumental in identifying people at risk of cardiovascular disease. Their researchers needed a solution that would allow them to ensure the integrity and accuracy of replicate data obtained for each individual sample in their study, thus increasing the statistical power of the study.

Using Radix BioSolutions' AssayCheX™, in conjunction with MasterPlex™ software from MiraiBio Group of Hitachi Software, Aviir has succeeded in dramatically improving the way they identify errors impacting the results from each individual sample well, flag them as outlier data, and remove just the impacted wells from the study.

By partnering with Radix BioSolutions, Aviir will be able to take the guesswork out of the process, and discover errors before they impact their studies. Explains Aviir Scientist Ali Vahedi, “Using AssayCheX process control beads leads to enhanced confidence in the data obtained, providing justification for the removal of outliers and improving the robustness of the xMAP assays. Having this capability will be invaluable in situations where sample volume is limited and retests are impossible.”